Description: Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. The company?s stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical program products include NSI?566, which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, and Phase I clinical trials for chronic spinal cord injury. The company?s clinical development products also comprise NSI?566 that is in Phase I/II clinical trials for motor deficits due to ischemic stroke in China; and NSI?189 that is in Phase Ib for the treatment of major depressive disorders. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.

Follow us

Copyright

We are constantly working on our website improvements. We need your help. Please give us some feedback by completing this short poll. It will only take a few minutes of your time but it means a lot to us.

What type of instruments do you invest in?

Forex

Stocks

ETFs

Future contracts

Options

Do you consider using trends when making investment decisions?

All the time

Very often

From time to time

Almost never

Not at all

Other

Do you consider the tools provided by our site helpful for your trading activities?

All the time

Very often

From time to time

Almost never

Not at all

Other

Do you find the our website easy-to-use when you look for specific information?

All the time

Very often

From time to time

Almost never

Not at all

Other

Do you use other stock market screeners?

All the time

Very often

From time to time

Almost never

Not at all

Other

What would you change about our website graphical design?

Do you understand how to use our tools, if not what can we do to improve that?

If you have any more comments e.g. what to add, any mistakes you came across etc. please share it with us.